医学
随机对照试验
克罗恩病
生活质量(医疗保健)
物理疗法
疾病
改变生活方式
内科学
重症监护医学
胃肠病学
护理部
作者
Nina Bauer,Claudia Löffler,Oezlem Oeznur,Christine Uecker,Christoph Schlee,Alexandra Adamczyk,Sigrid Elsenbruch,Katrin Pfuhlmann,Ralf Reißmann,Astrid M. Westendorf,Thomas Keil,Jost Langhorst
出处
期刊:Digestion
[Karger Publishers]
日期:2024-01-01
卷期号:105 (3): 201-212
被引量:8
摘要
<b><i>Introduction:</i></b> Stress and lifestyle factors impact the course of Crohn’s disease (CD). Our primary objective was to assess whether patients with CD benefit from a mind-body-medicine stress management and lifestyle modification (MBM) program. <b><i>Methods:</i></b> This 9-month two-arm pilot trial was conducted in Bamberg, Germany (2020–2021). Patients (18–75 years) with mild to moderate activity of CD and stable medication were enrolled and randomly assigned to either a 10-week MBM program (intervention group, IG) or a single 90-min education session (waiting list control group, CG). Primary endpoints were quality of life (IBDQ) and disease activity (HBI). Secondary endpoints were emotional distress, core self-evaluation, and inflammatory biomarkers 3 and 9 months after baseline assessment. <b><i>Results:</i></b> We analyzed data from 37 patients (IG: <i>n</i> = 19, mean ± SD age 49.6 ± 13.1 years, 68% female; CG: 18, 46.8 ± 11.4, 67% female). Immediately after the intervention, 79% (IG) and 44% (CG) experienced a clinically relevant improvement (IBDQ score ≥16 points). This was similar after 9 months (63% vs. 44%). There was no difference in disease activity (3 months: <i>p</i> = 0.082, 95% CI −1.3 to 2.6; 9 months: <i>p</i> = 0.251, 95% CI −1.2 to 2.5). Secondary outcomes indicated improvements in emotional distress, core self-evaluation, erythrocyte sedimentation rate after three and in emotional distress, T-cell profiling in the blood, and fecal lactoferrin and calprotectin group after 9 months in the IG. <b><i>Conclusion:</i></b> Our study suggested benefits of a multimodal stress management and lifestyle modification program for patients with CD. Larger trials are needed to determine if the program can supplement or at least partially replace pharmacological treatment approaches.
科研通智能强力驱动
Strongly Powered by AbleSci AI